Free Trial

Mizuho's Rating of Amylyx Pharmaceuticals on 11/10/2026

On November 10, 2026, Mizuho updated its outlook on Amylyx Pharmaceuticals (NASDAQ:AMLX) with the action "Boost Price Target", setting a price target of $39.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Mizuho

DateCompanyAction
11/13/2026
Cerebras Systems Inc. stock logo
CBRS
Cerebras Systems
Lower Price Target
11/13/2026
Applied Materials, Inc. stock logo
AMAT
Applied Materials
Lower Price Target
11/13/2026
Par Pacific Holdings, Inc. stock logo
PARR
Par Pacific
Lower Price Target
11/13/2026
Marathon Petroleum Corporation stock logo
MPC
Marathon Petroleum
Lower Price Target
11/13/2026
Delek US Holdings, Inc. stock logo
DK
Delek US
Lower Price Target
11/13/2026
Willis Towers Watson Public Limited Company stock logo
WTW
Willis Towers Watson Public
Boost Price Target
More Ratings From Mizuho